EBV renders B cells susceptible to HIV-1 in humanized mice

  • Donal McHugh
  • Renier Myburgh
  • Nicole Caduff
  • Michael Spohn
  • Yik Lim Kok
  • Christian W Keller
  • Anita Murer
  • Bithi Chatterjee
  • Julia Rühl
  • Christine Engelmann
  • Obinna Chijioke
  • Isaak Quast
  • Mohaned Shilaih
  • Victoria P Strouvelle
  • Kathrin Neumann
  • Thomas Menter
  • Stephan Dirnhofer
  • Janice Kp Lam
  • Kwai F Hui
  • Simon Bredl
  • Erika Schlaepfer
  • Silvia Sorce
  • Andrea Zbinden
  • Riccarda Capaul
  • Jan D Lünemann
  • Adriano Aguzzi
  • Alan Ks Chiang
  • Werner Kempf
  • Alexandra Trkola
  • Karin J Metzner
  • Markus G Manz
  • Adam Grundhoff
  • Roberto F Speck
  • Christian Münz

Beteiligte Einrichtungen

Abstract

HIV and EBV are human pathogens that cause a considerable burden to worldwide health. In combination, these viruses are linked to AIDS-associated lymphomas. We found that EBV, which transforms B cells, renders them susceptible to HIV-1 infection in a CXCR4 and CD4-dependent manner in vitro and that CXCR4-tropic HIV-1 integrates into the genome of these B cells with the same molecular profile as in autologous CD4+ T cells. In addition, we established a humanized mouse model to investigate the in vivo interactions of EBV and HIV-1 upon coinfection. The respective mice that reconstitute human immune system components upon transplantation with CD34+ human hematopoietic progenitor cells could recapitulate aspects of EBV and HIV immunobiology observed in dual-infected patients. Upon coinfection of humanized mice, EBV/HIV dual-infected B cells could be detected, but were susceptible to CD8+ T-cell-mediated immune control.

Bibliografische Daten

OriginalspracheEnglisch
ISSN2575-1077
DOIs
StatusVeröffentlicht - 08.2020

Anmerkungen des Dekanats

© 2020 McHugh et al.

PubMed 32576602